Department of Psychology, Temple University, United States.
Department of Psychology, Temple University, United States; Neuroscience Program, Temple University, United States.
Neurosci Biobehav Rev. 2021 Sep;128:358-366. doi: 10.1016/j.neubiorev.2021.06.038. Epub 2021 Jun 29.
Females are more vulnerable than males to many aspects of cocaine use disorder. This vulnerability also translates to opioid use disorder, with females exhibiting stronger behavioral responses than males to drugs such as heroin and morphine. While there is evidence for many overlapping neural mechanisms underlying cocaine and opioid abuse, there is also a breadth of evidence indicating divergent effects of the drugs on synaptic plasticity. This makes it unclear whether the behavioral sex differences seen in substance use disorder across different drugs of abuse rely on the same mechanisms. Ovarian hormones have consistently been implicated as drivers of the behavioral sex differences in cocaine taking and seeking. While there are far fewer studies on the role of ovarian hormones in opioid use disorder, the existing data suggest that ovarian hormones may not drive these behavioral effects in the same manner as in cocaine use disorder. This review highlights evidence that behavioral sex differences in substance use disorder might be driven by different mechanisms depending on drug class.
女性比男性更容易受到可卡因使用障碍的许多方面的影响。这种脆弱性也反映在阿片类药物使用障碍中,女性对海洛因和吗啡等药物的行为反应比男性更强。虽然有证据表明可卡因和阿片类药物滥用有许多重叠的神经机制,但也有大量证据表明这些药物对突触可塑性有不同的影响。这使得尚不清楚在不同滥用药物的物质使用障碍中观察到的行为性别差异是否依赖于相同的机制。卵巢激素一直被认为是导致可卡因摄入和寻求行为性别差异的驱动因素。虽然关于卵巢激素在阿片类药物使用障碍中的作用的研究要少得多,但现有数据表明,卵巢激素可能不会以与可卡因使用障碍相同的方式驱动这些行为效应。这篇综述强调了证据,表明物质使用障碍中的行为性别差异可能取决于药物类别,而由不同的机制驱动。